HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Schizophrenia and porphobilinogen deaminase gene polymorphisms: an association study.

Abstract
A genetic case-control study was conducted in a group of patients with schizophrenia (n = 67; DSM-III) and psychiatrically normal controls matched for ethnicity (n = 84), living in the same geographical area. Using three different DNA polymorphisms of the gene encoding porphobilinogen deaminase (PBGD), a candidate gene for schizophrenia, an association with schizophrenia could not be detected. No significant associations were detected even after sub-division of the cohort by ethnicity and by gender.
AuthorsV L Nimgaonkar, R Ganguli, S S Washington, A Chakravarti
JournalSchizophrenia research (Schizophr Res) Vol. 8 Issue 1 Pg. 51-8 (Oct 1992) ISSN: 0920-9964 [Print] Netherlands
PMID1358185 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • DNA
  • Hydroxymethylbilane Synthase
Topics
  • Adult
  • Alleles
  • Chromosome Mapping
  • Cohort Studies
  • DNA (genetics)
  • Female
  • Genotype
  • Humans
  • Hydroxymethylbilane Synthase (genetics)
  • Male
  • Middle Aged
  • Polymerase Chain Reaction
  • Polymorphism, Restriction Fragment Length
  • Risk Factors
  • Schizophrenia (diagnosis, genetics)
  • Schizophrenic Psychology

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: